$hellKing Friday, 05/27/16 12:45:01 PM Re: A deleted message Post # of 506 OT PRQR Are you talking about QR-010 thats already news? QR-010 is a first-in-class RNA-based oligonucleotide designed to address the underlying cause of the disease by repairing the mRNA defect encoded by the D F508 mutation in the CFTR gene of CF patients. The D F508 mutation is a deletion of three of the coding base pairs, or nucleotides, in the CFTR gene, which results in the production of a misfolded CFTR protein that does not function normally. QR-010 is designed to bind to the defective CFTR mRNA and guide the insertion of the three missing nucleotides, thus repairing the mRNA and subsequently producing wild-type, or normal CFTR protein. QR-010 is designed to be self-administered through a small, handheld aerosol delivery device, or nebulizer, in the form of a mist inhaled into the lungs. We believe this method could allow maximum exposure of QR-010 to the primary target organ, the lung, as well as significant exposure to other affected organs through systemic absorption into the blood. QR-010 has been granted orphan drug designation in the United States and the European Union. The QR-010 project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 633545. http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11397163 My posts are only my opinion. I don't know the future. Please don't take my posts as investment decisions. You have to do your own Due Diligence and make your own investment choices.